Action ANIX ANIXA BIOSCIENCES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Anixa Biosciences, Inc.

Actions

ANIX

US03528H1095

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
3,23 USD +8,39 % Graphique intraday de Anixa Biosciences, Inc. +3,53 % -16,75 %
18/04 Anixa Biosciences accueille Sanjay Juneja au sein de son comité consultatif sur le cancer CI
12/03 Anixa Biosciences, Inc. annonce ses résultats pour le premier trimestre clos le 31 janvier 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board
InvestorBrandMedia: Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Anixa Biosciences Initiates Higher Dosing in Phase 1 Study of Ovarian Cancer Treatment
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Anixa Biosciences Says Japan Grants Patent to Ovarian Cancer Vaccine Technology
Anixa Biosciences, Inc. Announces Japanese Patent on Ovarian Cancer Vaccine Technology
North American Morning Briefing : Stock Futures Steady as Earnings Season Ramps Up
Anixa Biosciences, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
North American Morning Briefing : Stock Futures -2-
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
North American Morning Briefing : Samsung Warning Knocks Tech Stocks
North American Morning Briefing : Stock Futures Struggle After Weak China Data
Anixa Biosciences to Present at Biotech Showcase 2024
Anixa Biosciences Unveils 'Positive' Results From Phase 1 Trial of Breast Cancer Vaccine
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ANIX
  4. Actualités Anixa Biosciences, Inc.
  5. Autres langues